Literature DB >> 16110532

Tau protein aggregation in the frontal and entorhinal cortices as a function of aging.

Wencheng Yang1, Lee Cyn Ang, Michael J Strong.   

Abstract

OBJECTIVES: The abnormal accumulation of tau protein is increasingly recognized as the neuropathological hallmark of a number of dementing illness in which frontotemporal lobar degeneration occurs. In this paper we examined the age-dependant deposition of tau protein in the frontal and entorhinal neocortices.
METHODS: We examined autopsy records from 1997 to 2002 and selected 87 cases (10 in each decade from 0 to 79 years of age, 7 in 80-89 decade) with no history of dementia or other neurodegenerative diseases, and for which neurodegenerative diseases were excluded neuropathologically. Archival paraffin-embedded frontal and entorhinal cortices were examined by both Gallyas-Braak silver staining and a panel of antibodies recognizing tau protein accumulation.
RESULTS: Tau neuronal aggregates were observed in both frontal and entorhinal cortices in the third decade. While the frontal neuronal tau aggregates remained infrequent in the remaining decades, the number and extent ofneuronal tau aggregates in the entorhinal cortex increased such that by the 7th decade the majority of cases showed extensive tau aggregate formation. The most consistent morphological observation was of dense, perikaryal neuronal tau-immunoreactive aggregates, similar to the total tau distribution, firstly presenting in cortical layers II and III and subsequently involving in layers IV-VI. Neuropil threads became maximal in the 9th decade in both frontal and entorhinal cortices. Astrocytic tau accumulation was first observed in both frontal and entorhinal cortices in the 6th decade, predominantly in layer I and subcortical white matter, and increased in number with aging. Extraneuronal tau reactive aggregates and coiled bodies were rarely observed in the entorhinal cortex, and when present, were scattered through layer II to VI.
CONCLUSIONS: We have observed an age-dependant pattern of neuronal, extraneuronal and glial tau protein accumulation in the entorhinal cortex in individuals without neurodegenerative diseases. In contrast, tau protein aggregation is infrequently observed in the frontal cortex as a function of aging.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110532     DOI: 10.1016/j.devbrainres.2005.02.004

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  10 in total

1.  Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.

Authors:  Amanda M Gleixner; Jessica M Posimo; Deepti B Pant; Matthew P Henderson; Rehana K Leak
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

Review 2.  The frontotemporal syndromes of ALS. Clinicopathological correlates.

Authors:  Michael Joseph Strong; Wencheng Yang
Journal:  J Mol Neurosci       Date:  2011-08-02       Impact factor: 3.444

3.  Age-dependent changes in neuronal distribution of CacyBP/SIP: comparison to tubulin and the tau protein.

Authors:  Anna Filipek; Gabriela Schneider; Anna Mietelska; Izabela Figiel; Grazyna Niewiadomska
Journal:  J Neural Transm (Vienna)       Date:  2008-05-28       Impact factor: 3.575

4.  Spatial discrimination deficits as a function of mnemonic interference in aged adults with and without memory impairment.

Authors:  Zachariah M Reagh; Jared M Roberts; Maria Ly; Natalie DiProspero; Elizabeth Murray; Michael A Yassa
Journal:  Hippocampus       Date:  2013-11-12       Impact factor: 3.899

5.  Threonine175, a novel pathological phosphorylation site on tau protein linked to multiple tauopathies.

Authors:  Alexander J Moszczynski; Wencheng Yang; Robert Hammond; Lee Cyn Ang; Michael J Strong
Journal:  Acta Neuropathol Commun       Date:  2017-01-11       Impact factor: 7.801

6.  Pathologic Thr175 tau phosphorylation in CTE and CTE with ALS.

Authors:  Alexander J Moszczynski; Wendy Strong; Kathy Xu; Ann McKee; Arthur Brown; Michael J Strong
Journal:  Neurology       Date:  2018-01-03       Impact factor: 9.910

Review 7.  Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder (ALS-FTSD). A Review.

Authors:  Alexander J Moszczynski; Matthew A Hintermayer; Michael J Strong
Journal:  Front Neurosci       Date:  2018-04-20       Impact factor: 4.677

Review 8.  Alterations in Tau Metabolism in ALS and ALS-FTSD.

Authors:  Michael J Strong; Neil S Donison; Kathryn Volkening
Journal:  Front Neurol       Date:  2020-11-23       Impact factor: 4.003

9.  Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis.

Authors:  Christopher M Henstridge; Dimitrios I Sideris; Emily Carroll; Sanziana Rotariu; Sally Salomonsson; Makis Tzioras; Chris-Anne McKenzie; Colin Smith; Christine A F von Arnim; Albert C Ludolph; Dorothée Lulé; Danielle Leighton; Jon Warner; Elaine Cleary; Judith Newton; Robert Swingler; Siddharthan Chandran; Thomas H Gillingwater; Sharon Abrahams; Tara L Spires-Jones
Journal:  Acta Neuropathol       Date:  2017-12-22       Impact factor: 17.088

10.  Regional white matter volume differences in nondemented aging and Alzheimer's disease.

Authors:  David H Salat; Douglas N Greve; Jennifer L Pacheco; Brian T Quinn; Karl G Helmer; Randy L Buckner; Bruce Fischl
Journal:  Neuroimage       Date:  2008-11-05       Impact factor: 6.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.